Exela Technologies and AIDEO Technologies Enter Strategic Alliance
Exela Technologies (NASDAQ: XELA) has announced a strategic alliance with AIDEO Technologies, a leading AI platform for autonomous coding in healthcare. This partnership aims to revolutionize medical billing by enhancing efficiency and accuracy. Exela's PCH Global, a healthcare platform, will expand its capabilities and customer base by integrating AIDEO's AI technology.
The collaboration aligns with Exela's initiative to incorporate generative AI across its products and services. Suresh Yannamani, CEO of Exela Technologies BPA, expressed excitement about bringing this innovative AI technology to their customers and PCH Global ecosystem. Tim Jones, Chief Revenue Officer of Aidéo Technologies, highlighted the opportunity to integrate their capabilities with PCH Global as a win for providers seeking to lower costs of processing claims and obtaining payment.
Exela Technologies (NASDAQ: XELA) ha annunciato una alleanza strategica con AIDEO Technologies, una piattaforma leader in intelligenza artificiale per la codifica autonoma nel settore sanitario. Questa partnership ha l'obiettivo di rivoluzionare la fatturazione medica migliorando efficienza e accuratezza. PCH Global di Exela, una piattaforma sanitaria, amplierà le sue capacità e il proprio bacino di clienti integrando la tecnologia AI di AIDEO.
La collaborazione è in linea con l'iniziativa di Exela di incorporare AI generativa nei suoi prodotti e servizi. Suresh Yannamani, CEO di Exela Technologies BPA, ha espresso entusiasmo per l'opportunità di portare questa innovativa tecnologia AI ai loro clienti e all'ecosistema PCH Global. Tim Jones, Chief Revenue Officer di AIDEO Technologies, ha sottolineato l'opportunità di integrare le loro capacità con PCH Global, rappresentando un vantaggio per i fornitori che cercano di ridurre i costi di elaborazione delle richieste e di ricezione dei pagamenti.
Exela Technologies (NASDAQ: XELA) ha anunciado una alianza estratégica con AIDEO Technologies, una plataforma líder en IA para la codificación autónoma en el sector de la salud. Esta asociación tiene como objetivo revolucionar la facturación médica mejorando la eficiencia y la precisión. PCH Global de Exela, una plataforma de atención médica, ampliará sus capacidades y base de clientes al integrar la tecnología de IA de AIDEO.
La colaboración está alineada con la iniciativa de Exela de incorporar IA generativa en sus productos y servicios. Suresh Yannamani, CEO de Exela Technologies BPA, expresó su entusiasmo por llevar esta innovadora tecnología de IA a sus clientes y al ecosistema de PCH Global. Tim Jones, Director de Ingresos de AIDEO Technologies, destacó la oportunidad de integrar sus capacidades con PCH Global como una victoria para los proveedores que buscan reducir los costos de procesamiento de reclamaciones y obtención de pagos.
Exela Technologies (NASDAQ: XELA)는 AIDEO Technologies와의 전략적 제휴를 발표했습니다. AIDEO Technologies는 의료 분야의 자율 코딩을 위한 선도적인 AI 플랫폼입니다. 이 파트너십의 목표는 의료 청구 시스템을 혁신화하는 것으로, 효율성과 정확성을 향상시키는 것입니다. Exela의 의료 플랫폼 PCH Global은 AIDEO의 AI 기술을 통합하여 역량과 고객 기반을 확장할 것입니다.
이번 협력은 Exela가 자체 제품과 서비스에 생성적 AI를 통합하려는 노력과 일치합니다. Exela Technologies BPA의 CEO인 Suresh Yannamani는 고객과 PCH Global 생태계에 이 혁신적인 AI 기술을 제공하게 되어 매우 기쁘다고 전했습니다. Aidéo Technologies의 수익 최고 책임자인 Tim Jones는 PCH Global과의 역량 통합이 청구 처리 비용을 줄이려는 공급자에게 도움이 되는 기회라고 강조했습니다.
Exela Technologies (NASDAQ: XELA) a annoncé une alliance stratégique avec AIDEO Technologies, une plateforme leader en IA pour la programmation autonome dans le secteur de la santé. Ce partenariat vise à révolutionner la facturation médicale en améliorant l'efficacité et la précision. PCH Global d'Exela, une plateforme de santé, élargira ses capacités et sa base de clients en intégrant la technologie IA d'AIDEO.
Cette collaboration s'inscrit dans l'initiative d'Exela d'incorporer l'IA générative dans ses produits et services. Suresh Yannamani, PDG d'Exela Technologies BPA, a exprimé son enthousiasme à l'idée d'apporter cette technologie IA innovante à leurs clients et à l'écosystème de PCH Global. Tim Jones, directeur des revenus d'AIDEO Technologies, a souligné l'opportunité d'intégrer leurs capacités avec PCH Global, ce qui représente un avantage pour les fournisseurs cherchant à réduire les coûts de traitement des demandes et d'obtention des paiements.
Exela Technologies (NASDAQ: XELA) hat eine strategische Allianz mit AIDEO Technologies angekündigt, einer führenden KI-Plattform für autonome Programmierung im Gesundheitswesen. Diese Partnerschaft zielt darauf ab, die medizinische Abrechnung zu revolutionieren, indem die Effizienz und Genauigkeit verbessert werden. PCH Global von Exela, eine Gesundheitsplattform, wird ihre Fähigkeiten und Kundenbasis erweitern, indem sie die KI-Technologie von AIDEO integriert.
Die Zusammenarbeit steht im Einklang mit Exelas Initiative, generative KI in ihre Produkte und Dienstleistungen zu integrieren. Suresh Yannamani, CEO von Exela Technologies BPA, äußerte sich begeistert über die Möglichkeit, diese innovative KI-Technologie ihren Kunden und dem Ökosystem von PCH Global zur Verfügung zu stellen. Tim Jones, Chief Revenue Officer von AIDEO Technologies, hob die Chance hervor, ihre Fähigkeiten mit PCH Global zu kombinieren, was einen Gewinn für Anbieter darstellt, die die Kosten der Bearbeitung von Ansprüchen und den Zahlungserhalt senken möchten.
- Strategic alliance with AIDEO Technologies to enhance medical billing efficiency
- Expansion of PCH Global platform capabilities and customer base
- Integration of generative AI across Exela's products and services
- None.
Insights
Exela Technologies' strategic partnership with AIDEO Technologies is a significant move within the healthcare technology sector. The collaboration aims to integrate AI solutions for medical coding and billing, which is a critical aspect of the healthcare revenue cycle. By leveraging generative AI, Exela can enhance the efficiency and accuracy of its billing processes, potentially leading to cost reductions and faster payment cycles for providers. This is likely to strengthen Exela's market position and broaden its customer base, particularly with its PCH Global platform, which already has a solid foothold in the industry. From a financial perspective, this alliance could drive revenue growth and improve margins by streamlining operations and reducing operational costs.
Integrating generative AI into medical coding and billing is a game-changer for both Exela and AIDEO Technologies. Generative AI has the potential to automate the complex and error-prone task of medical coding, ensuring higher accuracy and compliance with billing regulations. This integration can result in significant time savings and reduced administrative burdens for healthcare providers. Furthermore, it aligns with the broader trend of digital transformation in healthcare, where AI and automation are increasingly becoming central to operational efficiency and patient care. The strategic use of AI could also lead to innovative solutions that set new standards in the industry.
From a market perspective, this partnership could enhance the competitive edge of both Exela and AIDEO Technologies. The healthcare automation market is growing rapidly, driven by the need for cost reduction and improved operational efficiencies. By joining forces, Exela and AIDEO can offer a comprehensive suite of solutions that address critical pain points in the medical billing process. This collaboration might attract new clients who are looking for advanced, reliable and cost-effective healthcare automation solutions. Additionally, it could improve customer retention by providing existing clients with enhanced service offerings, thereby increasing long-term loyalty and recurring revenue streams.
Exela is a leader in healthcare technologies and Aideo is a Leading AI Platform for Autonomous Coding in Healthcare
IRVING, Texas, July 22, 2024 (GLOBE NEWSWIRE) -- Exela Technologies, Inc. (“Exela” or “the Company”) (NASDAQ: XELA, XELAP), a leader in business processing automation (“BPA”) announces a strategic alliance with AIDEO Technologies (AI Medical Coding & Billing Automation Revenue Cycle Management - aidéo-tech (aideo-tech.com), a leading AI platform specializing in autonomous coding for healthcare. This collaboration is poised to revolutionize the medical billing landscape by enhancing efficiency and accuracy across the board. Exela’s strategic initiative incorporates generative AI across its products and services, complementing other AI-driven efforts.
PCH Global, Exela’s industry leading Healthcare platform, continues to expand its capabilities and grow its customer base by providing solutions for providers and payers. This strategic partnership will further enhance value proposition for PCH Global customers by providing feature-rich, leading-edge solutions.
"We are excited to bring this innovative AI technology to our customers as well as our PCH Global ecosystem to Aideo customers," said Suresh Yannamani, CEO of Exela Technologies BPA.
“Medical coding is the lynch pin of the healthcare revenue cycle,” said Tim Jones, Chief Revenue Officer of Aidéo Technologies. “The opportunity to integrate our capabilities both up and downstream with PCH Global is a win for providers seeking to lower costs of processing claims and obtaining payment.”
For more information about this partnership and how it will benefit your coding and billing operations, please click on the link PCH Health | Providers, Payers & Members
For more Exela news, commentary, and industry perspectives, visit: https://investors.exelatech.com/
And please follow us on social:
Twitter: https://twitter.com/exelatech
LinkedIn: https://www.linkedin.com/company/exela-technologies
Facebook: https://www.facebook.com/exelatechnologies/
Instagram: https://www.instagram.com/exelatechnologies
The information posted on the Company's website and/or via its social media accounts may be deemed material to investors. Accordingly, investors, media and others interested in the Company should monitor the Company's website and its social media accounts in addition to the Company's press releases, SEC filings and public conference calls and webcasts.
About Exela Technologies
Exela Technologies is a business process automation (BPA) leader, leveraging a global footprint and proprietary technology to provide digital transformation solutions enhancing quality, productivity, and end-user experience. With decades of experience operating mission-critical processes, Exela serves a growing roster of more than 4,000 customers throughout 50 countries, including over
About AIDEO Technologies
Aidéo Technologies is a leading provider of AI-powered medical coding productivity solutions to the revenue cycle management industry. Creating scalable and repeatable coding efficiency, Aidéo Technologies’ Gemini Solution Suite empowers and complements medical coders with workflow efficiencies, artificial intelligence, and supplemental coding services. The Gemini Coder Platform™, Gemini AutoCode™, and Gemini Full Service™ solutions are optimized to work together for maximum impact in creating efficiency and improving accuracy through workflow improvements and autonomous and predictive coding.
Forward-Looking Statements
Certain statements included in this press release are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as "may", "should", "would", "plan", "intend", "anticipate", "believe", "estimate", "predict", "potential", "seem", "seek", "continue", "future", "will", "expect", "outlook" or other similar words, phrases or expressions. These forward-looking statements include statements regarding our industry, future events, estimated or anticipated future results and benefits, future opportunities for Exela, and other statements that are not historical facts. These statements are based on the current expectations of Exela management and are not predictions of actual performance. These statements are subject to a number of risks and uncertainties, including without limitation those discussed under the heading "Risk Factors" in Exela's Annual Report and other securities filings. In addition, forward-looking statements provide Exela's expectations, plans or forecasts of future events and views as of the date of this communication. Exela anticipates that subsequent events and developments will cause Exela's assessments to change. These forward-looking statements should not be relied upon as representing Exela's assessments as of any date subsequent to the date of this press release.
Investor, Media and Industry Contacts:
Vincent Kondaveeti
E: vincent.kondaveeti@exelatech.com
E: IR@exelatech.com
Industry research contact: Gaurav.Jamdar@Exelatech.com
FAQ
What is the purpose of Exela Technologies' strategic alliance with AIDEO Technologies?
How will the partnership benefit Exela's PCH Global platform?
What technology is Exela Technologies incorporating across its products and services?
